What's Behind the Recent Insider Selling at Soleno Therapeutics (SLNO)

Related Articles

What's Behind the Recent Insider Selling at AnaptysBio

1 months ago

What's Behind the Recent Insider Selling at Vicor

3 weeks ago

What's Behind the Recent Insider Selling at International Seaways

2 months ago

What's Behind the Recent Insider Selling at GigaCloud Technology

2 months ago

Category

You may also like

Stock News•1 week ago

This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million

Shares of the clinical-stage biotech rose 60% following the advancement of its Phase 3 clinical trial plans for an obesity drug. Meanwhile, an institutional fund divested $4.7M in company stock, signa...

GPCR

Share

Stock News•2 weeks ago

Capricor's Insider Just Sold Big — Her Options Tell the rest of the Story

Capricor Therapeutics reported a notable insider sale in its latest SEC filing. The transaction involves the exercise of options, signaling a potential shift in equity positioning for the biotech firm...

CAPR

Share

Stock News•4 weeks ago

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting DCCR Safety Timeline: SueWallSt

Soleno Therapeutics (NASDAQ: SLNO) faces a class action lawsuit alleging the company misrepresented DCCR safety timelines between March 26, 2025, and November 4, 2025. Investors who suffered losses du...

SLNO

Share

Stock News•1 months ago

A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million

Kailera Therapeutics (KLRA) insider purchased 500,000 shares for $8.0 million, according to recent SEC filings. This significant acquisition by company leadership signals confidence in the clinical-st...

KLRA

Share